@article{Qu2026, 
author = {Junyan Qu and Xinyao Liu and Min Quan and Fu Qiao and Hazrat Bilal and Wenjie Fang and Bin Xu and Yijian Chen and Jing Liu and Hong Peng and Jue Pan and Li Gu and Zhihui Zhou and Wenjie Yang and Ying Ge and Jingping Zhang and Jiabin Li and Xiaopan Wang and Anhua Wu and Nek Wali Shah Momin and Mohammad Daud Habib and Ajmal Khan Manduzai and Ahmed Nasir Hanifi and Atifa Popal and Chin Samnang and Abdella Gemechu and Surajit De Mandal and Pratibha Gaur and Pratibha Kale and Tejas Gohel and Vinaykumar Hallur and Bahareh Abbasi and Susan Farshi and Shahla Mohammad Ganji and Eisa Nasiri and Hamid Reza Jamaati and Leslie Thian Lung Than and Afreenish Amir and Rahat Ullah Khan and Waheed Iqbal and Irum Mehmood and  Nizamuddin and Matiur Rahman and Sijad Ur Rehman and Rani Faryal and Syeda Marriam Bakhtiar and Muhammad Nadeem Khan and Wei Liu and Zhiyong Zong},
title = {Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections},
year = {2026},
journal = {iFungi},
volume = {1},
number = {1},
pages = {9670007},
keywords = {Respiratory virus, Mucorales, Mucormycosis, SARS-CoV-2, Influenza virus, Prevention},
url = {https://www.sciopen.com/article/10.26599/iFungi.2026.9670007},
doi = {10.26599/iFungi.2026.9670007},
abstract = {The epidemiological patterns of respiratory viruses are complex and highly diverse. Infections caused particularly by SARS-CoV-2 and influenza viruses are frequently followed by secondary mucormycosis, posing significant challenges to clinical management and public health. To address the challenges posed by secondary mucormycosis following respiratory viral infections, the Fungal Prevention and Control Team of the Center for Infectious Diseases at West China Hospital, Sichuan University, convened experts from relevant disciplines across the world to develop the "Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections". This consensus aims to provide systematic guidance and optimize prevention strategies. It identifies high-risk populations for mucormycosis after respiratory viral infections and offers 12 preventive recommendations focusing on four areas: education and training, personal protection, early diagnosis and treatment, and infection control. The document also highlights key measures that remain controversial or insufficiently supported by evidence and outlines directions for future research to promote greater awareness and research of mucormycosis.}
}